These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37034629)

  • 1. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau.
    Mate de Gerando A; Welikovitch LA; Khasnavis A; Commins C; Glynn C; Chun JE; Perbet R; Hyman BT
    bioRxiv; 2023 May; ():. PubMed ID: 37034629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau.
    Mate De Gerando A; Welikovitch LA; Khasnavis A; Commins C; Glynn C; Chun JE; Perbet R; Hyman BT
    Acta Neuropathol; 2023 Aug; 146(2):191-210. PubMed ID: 37341831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
    Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
    J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo.
    Vergara C; Houben S; Suain V; Yilmaz Z; De Decker R; Vanden Dries V; Boom A; Mansour S; Leroy K; Ando K; Brion JP
    Acta Neuropathol; 2019 Mar; 137(3):397-412. PubMed ID: 30599077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
    Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
    J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
    J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease brain contains tau fractions with differential prion-like activities.
    Li L; Shi R; Gu J; Tung YC; Zhou Y; Zhou D; Wu R; Chu D; Jin N; Deng K; Xu J; Gong CX; Iqbal K; Liu F
    Acta Neuropathol Commun; 2021 Feb; 9(1):28. PubMed ID: 33597014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies.
    Ferrer I; Aguiló García M; Carmona M; Andrés-Benito P; Torrejón-Escribano B; Garcia-Esparcia P; Del Rio JA
    Front Aging Neurosci; 2019; 11():112. PubMed ID: 31191295
    [No Abstract]   [Full Text] [Related]  

  • 9. Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
    Wu R; Gu J; Zhou D; Tung YC; Jin N; Chu D; Hu W; Wegiel J; Gong CX; Iqbal K; Liu F
    J Alzheimers Dis; 2021; 79(4):1647-1659. PubMed ID: 33459649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum.
    Andrés-Benito P; Carmona M; Jordán M; Fernández-Irigoyen J; Santamaría E; Del Rio JA; Ferrer I
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy.
    Congdon EE; Lin Y; Rajamohamedsait HB; Shamir DB; Krishnaswamy S; Rajamohamedsait WJ; Rasool S; Gonzalez V; Levenga J; Gu J; Hoeffer C; Sigurdsson EM
    Mol Neurodegener; 2016 Aug; 11(1):62. PubMed ID: 27578006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dephosphorylation Passivates the Seeding Activity of Oligomeric Tau Derived From Alzheimer's Brain.
    Wu R; Li L; Shi R; Zhou Y; Jin N; Gu J; Tung YC; Liu F; Chu D
    Front Mol Neurosci; 2021; 14():631833. PubMed ID: 34054426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antisera to paired helical filaments and tau. Implication for the extent of tau tightly bound to paired helical filaments.
    Ihara Y; Kondo J; Miura R; Nakagawa Y; Mori H; Honda T
    Gerontology; 1990; 36 Suppl 1():15-24. PubMed ID: 1696559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dityrosine Cross-links are Present in Alzheimer's Disease-derived Tau Oligomers and Paired Helical Filaments (PHF) which Promotes the Stability of the PHF-core Tau (297-391) In Vitro.
    Maina MB; Al-Hilaly YK; Oakley S; Burra G; Khanom T; Biasetti L; Mengham K; Marshall K; Harrington CR; Wischik CM; Serpell LC
    J Mol Biol; 2022 Oct; 434(19):167785. PubMed ID: 35961386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.
    Takeda S; Commins C; DeVos SL; Nobuhara CK; Wegmann S; Roe AD; Costantino I; Fan Z; Nicholls SB; Sherman AE; Trisini Lipsanopoulos AT; Scherzer CR; Carlson GA; Pitstick R; Peskind ER; Raskind MA; Li G; Montine TJ; Frosch MP; Hyman BT
    Ann Neurol; 2016 Sep; 80(3):355-67. PubMed ID: 27351289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.
    Li L; Jiang Y; Hu W; Tung YC; Dai C; Chu D; Gong CX; Iqbal K; Liu F
    Mol Neurobiol; 2019 Sep; 56(9):6168-6183. PubMed ID: 30734228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
    Nicholls SB; DeVos SL; Commins C; Nobuhara C; Bennett RE; Corjuc DL; Maury E; Eftekharzadeh B; Akingbade O; Fan Z; Roe AD; Takeda S; Wegmann S; Hyman BT
    PLoS One; 2017; 12(5):e0177914. PubMed ID: 28531180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
    Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
    Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.